Loading product details…Cargando detalles del producto…Carregando detalhes do produto…

At a glance

AGORESEARCH
Specification
Category
Form
Knowledge source
Research focus
Reconstitution
Storage
COA

What is TSM10?

GHRH analog profile associated with visceral-fat and GH-axis research. The LPPEPTIDE knowledge record describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Tesamorelin 10mg is mapped to LPPeptide SKU TSM10. Current storefront values use our product data: 10mg x 10 vials /box, $169.00 USD per box. LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials.

Research context

The LPPEPTIDE knowledge record describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Research usually focuses on GHRH receptor signaling, pulsatile GH release, IGF-1 pathway markers, and metabolic endpoint tracking.

Commonly matched with

TSM10 is commonly reviewed alongside RT10, RT20, RT30, TR10, Sermorelin. Keep each combination tied to a defined research objective and lot record.

Compliance notice

TSM10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Research usually focuses on GHRH receptor signaling, pulsatile GH release, IGF-1 pathway markers, and metabolic endpoint tracking.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 5mg x 10 vials / 10mg x 10 vials.

Dosing & Protocol

LPPeptide handling reference

LPPEPTIDE knowledge source: add 2.0 mL bacteriostatic water per 10 mg vial for 5.0 mg/mL. Standard reference amount is once daily 2 mg. At 5.0 mg/mL, 1 U equals 50 mcg.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

Tesamorelin 10mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 2.0 mL bacteriostatic water per 10 mg vial for 5.0 mg/mL. Standard reference amount is once daily 2 mg. At 5.0 mg/mL, 1 U equals 50 mcg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: 2-8 deg C. Reconstituted with bacteriostatic water: 2-8 deg C and use within 7 days. Do not freeze the prepared solution.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Commonly reviewed signals include fluid retention, glucose markers, injection-site response, and GH-axis sensitivity.

Contraindications

Do not use TSM10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review combinations with sermorelin, CJC-1295, ipamorelin, IGF-axis materials, or glucose-pathway compounds.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps TSM10 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: TSM10
  • Product: Tesamorelin 10mg
  • Storefront specification: 10mg x 10 vials /box
  • LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials
  • Listed box price: $169.00 USD
  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
About LPPeptide

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is TSM10?

GHRH analog profile associated with visceral-fat and GH-axis research. Coze describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Tesamorelin 10mg is mapped to LPPeptide SKU TSM10. Current storefront values use our product data: 10mg x 10 vials /box, $169.00 USD per box. LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials.

Research context

Coze describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Research usually focuses on GHRH receptor signaling, pulsatile GH release, IGF-1 pathway markers, and metabolic endpoint tracking.

Commonly matched with

TSM10 is commonly reviewed alongside RT10, RT20, RT30, TR10, Sermorelin. Keep each combination tied to a defined research objective and lot record.

Compliance notice

TSM10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

Coze describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Research usually focuses on GHRH receptor signaling, pulsatile GH release, IGF-1 pathway markers, and metabolic endpoint tracking.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 5mg x 10 vials / 10mg x 10 vials.

Dosing & Protocol

LPPeptide handling reference

Coze source: add 2.0 mL bacteriostatic water per 10 mg vial for 5.0 mg/mL. Standard reference amount is once daily 2 mg. At 5.0 mg/mL, 1 U equals 50 mcg. Coze preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

Tesamorelin 10mg ships as Lyophilized powder. Reconstitution note: Coze source: add 2.0 mL bacteriostatic water per 10 mg vial for 5.0 mg/mL. Standard reference amount is once daily 2 mg. At 5.0 mg/mL, 1 U equals 50 mcg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: 2-8 deg C. Reconstituted with bacteriostatic water: 2-8 deg C and use within 7 days. Do not freeze the prepared solution.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Commonly reviewed signals include fluid retention, glucose markers, injection-site response, and GH-axis sensitivity.

Contraindications

Do not use TSM10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review combinations with sermorelin, CJC-1295, ipamorelin, IGF-axis materials, or glucose-pathway compounds.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps TSM10 visible so the SKU can be matched to the active COA.

Current catalog summary

- SKU: TSM10 - Product: Tesamorelin 10mg - Storefront specification: 10mg x 10 vials /box - LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials - Listed box price: $169.00 USD - Reference: LPPeptide product knowledge record

Testing checklist

- Peptide identity or material identity - HPLC purity or assay result where applicable - Batch ID and test date - Sterility/endotoxin or accessory checks when applicable - Residual solvent and handling notes where applicable

About LPPeptide

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is TSM10?

GHRH analog profile associated with visceral-fat and GH-axis research. Coze describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Tesamorelin 10mg is mapped to LPPeptide SKU TSM10. Current storefront values use our product data: 10mg x 10 vials /box, $169.00 USD per box. LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials.

Research context

Coze describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Research usually focuses on GHRH receptor signaling, pulsatile GH release, IGF-1 pathway markers, and metabolic endpoint tracking.

Commonly matched with

TSM10 is commonly reviewed alongside RT10, RT20, RT30, TR10, Sermorelin. Keep each combination tied to a defined research objective and lot record.

Compliance notice

TSM10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

Coze describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Research usually focuses on GHRH receptor signaling, pulsatile GH release, IGF-1 pathway markers, and metabolic endpoint tracking.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 5mg x 10 vials / 10mg x 10 vials.

Dosing & Protocol

LPPeptide handling reference

Coze source: add 2.0 mL bacteriostatic water per 10 mg vial for 5.0 mg/mL. Standard reference amount is once daily 2 mg. At 5.0 mg/mL, 1 U equals 50 mcg. Coze preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

Tesamorelin 10mg ships as Lyophilized powder. Reconstitution note: Coze source: add 2.0 mL bacteriostatic water per 10 mg vial for 5.0 mg/mL. Standard reference amount is once daily 2 mg. At 5.0 mg/mL, 1 U equals 50 mcg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: 2-8 deg C. Reconstituted with bacteriostatic water: 2-8 deg C and use within 7 days. Do not freeze the prepared solution.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Commonly reviewed signals include fluid retention, glucose markers, injection-site response, and GH-axis sensitivity.

Contraindications

Do not use TSM10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review combinations with sermorelin, CJC-1295, ipamorelin, IGF-axis materials, or glucose-pathway compounds.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps TSM10 visible so the SKU can be matched to the active COA.

Current catalog summary

- SKU: TSM10 - Product: Tesamorelin 10mg - Storefront specification: 10mg x 10 vials /box - LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials - Listed box price: $169.00 USD - Reference: LPPeptide product knowledge record

Testing checklist

- Peptide identity or material identity - HPLC purity or assay result where applicable - Batch ID and test date - Sterility/endotoxin or accessory checks when applicable - Residual solvent and handling notes where applicable

About LPPeptide

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.